Table 8. Summary of Atmospheric CO2 Fixation over MOFsa.
| Sr. No. | MOF | Reactive site | Reactant | Product | Reaction conditions | Ref |
|---|---|---|---|---|---|---|
| 1 | (I–)Meim-UiO-66 | Zr4+, I– | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 0.1 MPa, 120 °C, 24 h | (248) |
| 2 | MIL-IL(A) | Cr3+, Br– | SO | 4-phenyl-1,3-dioxolan-2-one | 2 MPa, 110 °C, 2 h | (325) |
| MIL-IL(B) | ||||||
| 3 | MIL-IMAc-Br– | Cu2+-COOH, Br– | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 0.5 MPa, 60 °C, 24 h | (81) |
| 4 | Mg-MOF-74 | Mg2+, Co2+, OH | SO | 4-phenyl-1,3-dioxolan-2-one | 2 MPa, 100 °C, 4 h | (326, 327) |
| Co-MOF-74 | ||||||
| 5 | UiO-66-NH2 | Zr4+, NH2 | SO | 4-phenyl-1,3-dioxolan-2-one | 2.0 MPa, 100 °C, 4 h | (328) |
| 6 | BIT-101 | Zn2+, COO | PO | 4-methyl-1,3-dioxolan-2-one | 3 MPa, 160 °C, 24 h | (329) |
| BIT-102 | ||||||
| BIT-103 | ||||||
| 7 | 1-NH2 | CONH, NH2 | ECH, PO | 4-(chloromethyl)-1,3-dioxolna-2-one-4-methyl-1,3-dioxolan-2-one | 0.1 MPa, 90 °C, 50 h, 3 MPa, 100 °C, 6 h | (330) |
| 8 | UMCM-1-NH2 | Zn4O, NH2 | PO | 4-methyl-1,3-dioxolan-2-one | 1.2 MPa, 120 °C, 24 h | (331) |
| 9 | Zn-TATAB | Zn2+, NH | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 1 atm, 100 °C, 16 h | (332) |
| 10 | Co/Ni-TATAB | Co2+, Ni2+, NH | ECHECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 1 bar, 80 °C, 15 h | (279) |
| 11 | Zn-BTC-2MeIm | Zn2+, 2MeIm | ECH, PO | 4-(chloromethyl)-1,3-dioxolan-2-one | 3.0 MPa, 100 °C, 6 h | (333) |
| 12 | Co(tp)(bpy) MOF-508a | Co2+, Zn2+, free pyridine N | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 1 MPa, 100 °C, 8 h | (334) |
| 13 | (Me2NH2)2·[Zn8(Ad)4(DABA)6O]·7DMF}n | Zn2+, Ad, and NH2 | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 1 bar, 100 °C, 24 h | (335) |
| 14 | ZIF-8 | Zn2+, Im | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 7 bar, 100 °C, 4 h | (336) |
| 15 | ZIF-90 | Zn2+, CHO | PO | 4-methyl-1,3-dioxolan-2-one | 2 MPa, 120 °C, 8 h | (337) |
| 16 | CZ-ZIF | Zn2+/Co2+, HmIm | ECHPO | 4-(chloromethyl)-1,3-dioxolan-2-one | 7 bar, 100 °C, 4 h | (338) |
| 17 | ZIF-67 | Co2+, HmIm | ECHPO | 4-(chloromethyl)-1,3-dioxolan-2-one | 10 bar, 120 °C, 6 h | (339) |
| 18 | Ti-ZIF | Ti4+, Im | SO | 4-phenyl-1,3-dioxolan-2-one | 1.72 bar, 100 °C, 8 h | (340) |
| 19 | MIL-101-P(n-Bu)3BrMIL-101-N(n Bu)3Br | Cr3+, Br– | POPO | 4-methyl-1,3-dioxolan-2-one | 2.0 MPa, 80 °C, 8 h | (341) |
| 20 | F-ZIF-90 | Zn2+, I– | AGE | 4-((allyloxy)methyl)-1,3-dioxolan-2-one | 1.17 MPa, 120 °C, 6 h | (342) |
| 21 | IL-ZIF-90 | Zn2+, I– | PO | 4-methyl-1,3-dioxolan-2-one | 1.0 MPa, 120 °C, 3 h | (343) |
| 22 | ZnTCPP⊂(Br)Etim-UiO-66 | Zn2+, Br– | AGE | 4-((allyloxy)methyl)-1,3-dioxolan-2-one | 1 bar, 140 °C, 14 h | (344) |
| 23 | Salen-Co(23%)⊂(Br–)Etim-UiO- 66 | Co3+, Br– | SO | 4-phenyl-1,3-dioxolan-2-one | 0.1 MPa, 120 °C,12 h | (345) |
| 24 | UiO-67-IL | Zr4+, Br– | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 1 atm, 90 °C, 12 h | (346) |
| 25 | FJI-C10 | Cr3+, Br– | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 1 bar, 80 °C, 12 h | (347) |
| 26 | IL@MIL101-SO3H(4) | Cr3+, Br– | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 1 atm, 90 °C, 24 h | (348) |
| 27 | MIL-101-IMBr-6 | Cr3+, Br– | PO | 4-methyl-1,3-dioxolan-2-one | 0.8 MPa, 80 °C, 4 h | (349) |
| 28 | IL/MIL-101-NH2 | -COOH, NH2 | PO | 4-methyl-1,3-dioxolan-2-one | 1.3 MPa, 120 °C, 1 h | (350) |
| 29 | polyILs@MIL-101 | Cr3+, Br– | SO | 4-phenyl-1,3-dioxolan-2-one | 1 bar, 70 °C, 48 h | (351) |
| 30 | MIL-101-IP | Cr3+, Br– | PO | 4-methyl-1,3-dioxolan-2-one | 1 atm, 25 °C, 48 h | (352) |
| 31 | IL@ZIF-8(Zn/Co) | Zn2+, Co2+, Br– | SO | 4-phenyl-1,3-dioxolan-2-one | 1 atm, 100 °C, 24 h | (353) |
| 32 | F-IRMOF-3-2d | Zn4O, -NH2, I– | POPOPO | 4-methyl-1,3-dioxolan-2-one | 2 MPa, 140 °C, 1.5 h | (354) |
| F-IRMOF-3-4d | ||||||
| F-IRMOF-3-6d | ||||||
| 33 | F-IRMOF-3(MeI) | Zn-OH, I– | AGE | 4-((allyloxy)methyl)-1,3-dioxolan-2-one | 1.2 MPa, 120 °C, 6 h | (355) |
| F-IRMOF-3(BuI) | ||||||
| 34 | MIL-101-tmzOH-Br | Cr3+, OH–, Br– | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 1 MPa, 80 °C, 2 h | (356) |
| 35 | 2MeIm@Co-BTC-x | Co2+, MeIm | ECHECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 3.0 MPa, 90 °C, 5 h, 3.0 MPa, 90 °C, 7 h | (357) |
| 36 | Cr-MIL-101-[BuPh3P]Br | Cr3+, Br– | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 1 MPa, 80 °C, 2 h | (358) |
| 37 | [TMPyPMn(I)]4+(I–)4@ZIF-8 | Zn2+, Mn2+, I– | ECH | 4-(chloromethyl)-1,3-dioxolan-2-one | 1 bar, 100 °C, 36 h | (359) |
| 38 | [Zn(II)NMeTPyP]4+[I–]4@PCN- 224 | Zn2+, I– | ECHPO | 4-(chloromethyl)-1,3-dioxolan-2-one-4-methyl-1,3-dioxolan-2-one | 0.8 MPa, 90 °C, 24 h | (360) |
Abbreviations: ECH = epichlorohydrin; PO = propylene oxide; SO = styrene oxide; AGE = allyl glycidyl ether; dhtp = 2,5-dihydroxyterephthalate; NH2-BDC = 2-aminoterephthalate; aip = 5-aminoisophthalic acid; NIP = 5-nitroisophthalic acid; L = N4,N4′-di(pyridine-4-yl) biphenyl-4,4′-dicarboxamide; Im = imidazole; BTC = 1,3,5-benzene tricarboxylate; HmIm = 2-methylimidazole; ICA = imidazole 2-carboxaldehyde; TATAB = 4,4′,4″-s-triazine-1,3,5-triyl-tri-p-aminobenzoic acid; DABCO = 1,4-diazabicyclo[2.2.2]-octane; MIL = Materials Institute Lavoisier; UiO = University of Oslo; BIT = Beijing Institute of Technology; Hip = 5-hydroxyisophthalic acid; Bpy = 4,4′-bipyridine; BTB = 1,3,5-tris(4-carboxyphenyl)benzene; DMF = N,N′-dimethylformamide; Ad = adeninate; DABA = 2,2′-dimethyl- 4,4′-azobenzoate; 2-MeIm = 2-methylimidazole; ZIF = zeolitic imidazolate framework; 2-F-BIM = 2-(furan-2-yl)-1H-benzo[d]imidazole; TCPP = 5,10,15,20-tetrakis(4-carboxyphenyl)porphyrin; IL = ionic liquid; ICA = imidazole-2-carboxyaldehyde; Etim = ethyl imidazolium; polyILs = poly(ionic liquids); IP = ionic polymer; MeI = methyl iodide; BuI = butyl iodide; IRMOF = isoreticular metal–organic framework; IMAc = 1H-imidazole-1-acetic acid; PCN = Porous coordination network; Zn(II)NMeTPyP = 5,10,15,20-tetrakis(1-methylpyridinium-4-yl) zinc(II) porphyrin; [(Etim-H2BDC)+(Br)] = 2-(3-ethyl-imidazol-1-yl)-terephthalic acid; ImBDC = 2-(imidazole-1-yl)terephthalate; salen-Co(III) - N,N′-bis(3-carboxylsalicylidene)-1,2-cyclohexanediamino cobalt(III) acetate; [BuPh3P]Br = 4-(bromobutyl)triphenylphosphonium bromide; MPImBr = 1-methyl-3-propylimidazolium bromide; HmIm = 2-methylimidazole; 2-Br-BDC = 2-bromoterephthalate; L = (Br) allylium-2-bp functionalized biphenyl dicarboxylic acid.